FINWIRES · TerminalLIVE
FINWIRES

DroneShield Launches Portable Radio Frequency Intelligence Product

By

DroneShield (ASX:DRO) launched its RfRecon portable radio frequency intelligence product designed for dismounted, vehicle-mounted, expeditionary, and fixed-site operations, according to a Monday filing with the Australian bourse.

RfRecon allows operators to quickly sense, identify, and assess radio frequency activity from a single device and is the flagship product in the company's next-generation of counter-drone offerings, DroneShield said.

The company said there is "potential for orders being received and revenue contribution" starting in the second half of the year.

DroneShield shares gained over 1% in recent Monday trade.

Related Articles

Asia

Aspial Lifestyle's H1 Attributable Profit Surges 88%

Aspial Lifestyle's (SGX:5UF) recorded an 88% rise in attributable profit in the first half of 2026 to SG$52.4 million from SG$27.9 million a year prior.Earnings per share stood at SG$0.0277, up from SG$0.015 previously, according to a Friday filing with the Singapore bourse.Revenue jumped 26% to SG$464.2 million from SG$367.2 million in the year-ago period.

SGX:5UF
Asia

Sino Biopharma Unit Gets China Nod to Market Lung Cancer Drug

Sino Biopharmaceutical (HKG:1177) unit Chia Tai Tianqing Pharmaceutical Group's Benmelstobart Injection obtained marketing approval from China's National Medical Products Administration, according to a Friday Hong Kong bourse filing.The approval is for use of the drug in combination with chemotherapy and sequentially followed by Anlotinib Hydrochloride Capsules for the first-line treatment of locally advanced or metastatic squamous non-small cell lung cancer.

HKG:1177
Asia

Lygend Resources Gets CSRC Nod for China Listed-Share IPO

Lygend Resources & Technology (HKG:2245) obtained approval for its registration application related to its China listed-share initial public offering from the China Securities Regulatory Commission (CSRC).The share offering is subject to various conditions, including certain final regulatory approvals, according to a Friday Hong Kong bourse filing.

HKG:2245